ALB and acute-on-chronic liver failure: A variety of factors contribute to this finding, including differences in HRS-AKI diagnostic criteria that delayed the timing of terlipressin administration, the presence of acute-on-chronic liver failure (ACLF) with associated multiorgan dysfunction, and cumulative albumin dosage.